Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-24-000005

Options or other derivatives

  • Chief Executive Officer acquired 49,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BUNKA CHRISTOPHER Chief Executive Officer 2024-04-26 Grant or award · Stock Options +49,500 180,501 D: show line 1 in the form
Loading xslF345X05/primary_doc.xml…